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ABSTRACT The invasion-associated type III secretion system (T3SS-1) of Salmonella enterica serotype Typhimurium (S. Typhi-
murium) activates the transcription factor NF-B in tissue culture cells and induces inflammatory responses in animal models
through unknownmechanisms. Here we show that bacterial delivery or ectopic expression of SipA, a T3SS-1-translocated pro-
tein, led to the activation of the NOD1/NOD2 signaling pathway and consequent RIP2-mediated induction of NF-B-dependent
inflammatory responses. SipA-mediated activation of NOD1/NOD2 signaling was independent of bacterial invasion in vitro but
required an intact T3SS-1. In the mouse colitis model, SipA triggered mucosal inflammation in wild-type mice but not in NOD1/
NOD2-deficient mice. These findings implicate SipA-driven activation of the NOD1/NOD2 signaling pathway as a mechanism
by which the T3SS-1 induces inflammatory responses in vitro and in vivo.
IMPORTANCE Salmonella enterica serotype Typhimurium (S. Typhimurium) deploys a type III secretion system (T3SS-1) to in-
duce intestinal inflammation and benefits from the ensuing host response, which enhances growth of the pathogen in the intesti-
nal lumen. However, the mechanisms by which the T3SS-1 triggers inflammatory responses have not been resolved. Here we
show that the T3SS-1 effector protein SipA induces NF-B activation and intestinal inflammation by activating the NOD1/
NOD2 signaling pathway. These data suggest that the T3SS-1 escalates innate responses through a SipA-mediated activation of
pattern recognition receptors in the host cell cytosol.
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The principal pathogenic strategy of Salmonella enterica sero-type Typhimurium (S. Typhimurium) is to use its virulence
factors to elicit acute intestinal inflammation (1). A by-product of
this host response is the generation of a new respiratory electron
acceptor, tetrathionate, which enables the pathogen to outgrow
other microbes in the intestinal lumen (2), thereby enhancing its
transmission (3). S. Typhimurium utilizes a type III secretion sys-
tem (T3SS-1) encoded by Salmonella pathogenicity island 1 (SPI
1) to elicit intestinal inflammation in animal models (1, 4). The
principal function of the T3SS-1 is to deliver proteins, termed
effectors, into host cells (5, 6). Five T3SS-1 effectors, termed SipA,
SopA, SopB, SopD, and SopE2, act in concert to trigger alterations
in the actin cytoskeleton of host cells, thereby promoting epithelial
invasion (7–11) and intestinal inflammation (12). S. Typhimu-
rium induces activation of mitogen-activated protein (MAP) ki-
nases, activation of nuclear factor kappa-light-chain-enhancer of
activated B cells (NF-B), and production of proinflammatory
cytokines in cultured cell lines in a T3SS-1-dependent fashion
(13), suggesting that cytosolic access by the T3SS-1 triggers host
cell responses.
Several mechanisms through which cytosolic access by the
T3SS-1 can induce inflammatory responses have been proposed.
These mechanisms have in common that cytosolic access by the
T3SS-1 is detected by host macrophages via cytosolic recognition
of translocated bacterial proteins, resulting in caspase 1 activation
and consequent proteolytic activation of interleukin-1 (IL-1)
and IL-18, two proinflammatory cytokines (14–16).However, it is
also clear that these mechanisms are not sufficient to explain im-
portant in vitro and in vivo observations, suggesting that addi-
tional pathways by which the T3SS-1 induces inflammatory re-
sponses remain to be discovered. Specifically, activation of caspase
1 cannot account for the T3SS-1-dependent activation of NF-B
observed in vitro (13). Furthermore, the invasion-associated
T3SS-1 of S. Typhimurium elicits intestinal inflammation in vivo
through a myeloid differentiation primary response protein 88
(MyD88)-independent mechanism (17). Caspase 1 activation
does not explain the generation of these MyD88-independent
proinflammatory responses, because MyD88 is required for sig-
naling through receptors for IL-1 and IL-18 (18–20). Here we
identify a new MyD88-independent mechanism by which the
T3SS-1 induces host cell responses in vitro and demonstrate that
this mechanism contributes to S. Typhimurium-induced intesti-
nal inflammation in vivo.
RESULTS
NF-B activation by the invasion-associated T3SS is invasion
independent. The invasion-associated T3SS-1 of S. Typhimu-
rium activates NF-B in human epithelial cells (see Fig. S1A in the
supplemental material) (13, 21). To analyze whether this process
is invasion dependent, we used human epithelial cells transfected
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with an NF-B luciferase reporter construct. A T3SS-1-deficient
S. Typhimurium mutant (invA mutant) neither activated NF-B
(Fig. 1A) nor invaded epithelial HeLa cells (Fig. S1B). Introduc-
tion of the Yersinia pseudotuberculosis invasin protein (22) in-
creased invasiveness of the T3SS-1-deficient S. Typhimuriummu-
tant (P  0.05) but did not restore NF-B activation. Similar
results were obtained with human embryonic kidney 293
(HEK293) cells, although inactivation of the invasion-associated
T3SS resulted only in a partial inhibition of NF-B activation in
this cell line (Fig. S1C and S1D).
The T3SS-1 effectors SipA, SopA, SopB, SopD, and SopE2 act
in concert to promote invasion of epithelial cells (10). An S. Ty-
phimurium mutant lacking these five effector proteins (sipA sop-
ABDE2mutant) was deficient for invasion (P 0.05) and NF-B
activation (P  0.05) (see Fig. S1 in the supplemental material).
Introduction of the Y. pseudotuberculosis invasin protein into the
sipA sopABDE2 mutant restored invasiveness (P  0.05) but not
NF-B activation. These data suggested that NF-B activation re-
quired delivery of T3SS-1 effector proteins but not bacterial inva-
sion.
SipA is a keymediator of NF-B activation in vitro.To deter-
mine whether host cells can sense delivery of specific effectors, we
complemented the S. Typhimurium sipA sopABDE2mutant with
plasmids encoding SipA, SopA, SopB, SopD, or SopE2 (10) and
monitored NF-B activation (Fig. 1). Only a plasmid encoding
SipA complemented the sipA sopABDE2 mutant for NF-B acti-
vation in epithelial HeLa cells (P  0.05) (Fig. 1A). Endogenous
TLR5 expression renders HEK293 cells responsive to stimulation
with flagellin (23, 24), which might explain why we observed
NF-B activation in response to infectionwith the sipA sopABDE2
mutant or to stimulation with purified S. Typhimurium flagellin
(FliC) (P 0.05) in this cell line (Fig. 1A and 1B). Consistent with
FIG 1 SipA-mediated activation of NF-B in HeLa and HEK293 cells is MyD88 independent. (A) HeLa cells (gray bars) and HEK293 cells (black bars)
transfected with an NF-B luciferase reporter construct were infected with the S. Typhimurium sipA sopABDE2mutant complemented with genes encoding the
indicated effector proteins. (B)HEK293 cells were transfectedwithMyD88DNand infectedwith the S. Typhimurium sipA sopABDE2mutant and complemented
derivatives. Data represent the NF-B luciferase activity as fold increase over the uninfected controls. Values are the means from at least 3 independent
experiments standard errors. Brackets indicate the statistical significance of differences. NS, not significant.
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this idea, transfection of HEK293 cells with a plasmid encoding a
dominant-negative form of the TLR5 adaptor protein MyD88
(MyD88DN) abrogated NF-B activation induced by the sipA
sopABDE2 mutant or purified flagellin (Fig. 1B). Complementa-
tion of the sipA sopABDE2 mutant with plasmids encoding SipA
or SopE2 induced NF-B activation in HEK293 cells transfected
withMyD88DN (P 0.05) (Fig. 1B). Collectively, these data sug-
gested that bacterial delivery of SipA activates NF-B through a
MyD88-independent mechanism.
To determine whether SipA is sufficient for NF-B activation,
a green fluorescent protein (GFP)-SipA fusion protein was ex-
pressed ectopically in HEK293 cells transfected with an NF-B
luciferase reporter construct (Fig. 2). Ectopic expression of GFP-
SipA, but not ectopic expression of GFP, resulted in NF-B acti-
vation (P 0.05). These data suggested that cytosolic localization
of SipA in the absence of other bacterial molecules was sufficient
for inducing NF-B activation in host cells.
The SipA protein contains an N-terminal domain required for
T3SS-1 translocation (NTD), a C-terminal actin-binding domain
(ABD), and two central domains mediating SipA focus formation
(F1) and SipA-SipA interaction (F2) (25). GFP-SipA fusion pro-
teins lacking one or several of these domains were constructed to
investigate which domain(s) is required for NF-B activation
(Fig. 2A). Ectopic expression of these fusion proteins in HEK293
cells suggested that the F2 domain, which is not required for host
cell invasion (25), was necessary but not sufficient for NF-B ac-
tivation (P  0.05) (Fig. 2B; see also Fig. S2 in the supplemental
material). In contrast, the ABD, which is required to support
S. Typhimurium host cell invasion (25), was not necessary for
NF-B activation.
To determine whether the F2 domain was necessary for NF-B
activation upon bacterial delivery of SipA, we complemented the
sipA sopABDE2 mutant with plasmids carrying truncated sipA
genes encoding the first 425 amino acids (aa) (sipA’1-425), the
FIG 2 The F2 domain of SipA is necessary but not sufficient for NF-B activation. (A) Schematic representation of the SipA domain structure (top). The
composition of GFP-SipA fusion proteins is indicated below. (B) HEK293 cells were cotransfected with anNF-B luciferase reporter construct and the indicated
GFP-SipA fusion proteins. At 48 hours after transfection, cells were lysed to measure luciferase activity. Data represent the means standard errors of at least
three independent experiments.
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first 290 amino acids (sipA’1-290), or the first 149 amino acids
(sipA’1-149) of SipA. Complementation of the sipA sopABDE2
mutant with genes encoding full-length SipA or a truncated SipA
lacking the ABD (sipA’1-425) resulted in NF-B activation
through a MyD88-independent mechanism (Fig. 3). In contrast,
NF-B activation was not observed with proteins lacking the F2
domain, which were encoded by sipA’1-290 and sipA’1-149. In
summary, the F2 domain was necessary for NF-B activation re-
gardless of whether SipA was delivered by bacteria or expressed
ectopically.
SipA-mediatedNF-B activation requires RIP2 in vitro.One
MyD88-independent mechanism contributing to intestinal in-
flammation during S. Typhimurium infection is the activation of
nucleotide-binding and oligomerization domain 1 (NOD1) and
NOD2, two intracellular sensors of bacterial cell wall fragments
(26, 27). NOD1 and NOD2 interact with protein kinase receptor-
interacting protein 2 (RIP2) tomediateNF-B activation (28, 29).
Stimulation of HEK293 cells with the NOD1 ligand C12-iE-DAP
resulted in NF-B activation (P 0.05), which was MyD88 inde-
pendent and could be inhibited with SB203580 (Fig. 3B and 3D),
a pyridinyl imidazole inhibitor of RIP2 activity (30). NF-B acti-
vation induced by bacterial delivery of SipA was abrogated when
cells were treated with the RIP2 inhibitor SB203580 (Fig. 3A and
3C). These data suggested that SipA-mediated NF-B activation
required RIP2.
SipA-mediated NF-B activation requires both NOD1 and
NOD2 in vitro. We next investigated whether NOD1 or NOD2
was required for SipA-dependent NF-B activation (Fig. 4).
FIG 3 The RIP2 inhibitor SB203580 inhibits SipA-mediated NF-B activation. HEK293 cells were transfected with an NF-B luciferase reporter construct (A
and B) andMyD88DN (C andD). Thirty minutes before infection of the cells with the indicated S. Typhimurium strains, the cells were pretreated with dimethyl
sulfoxide (black bars) or with 10 M SB203580 (white bars). After 5 h, the cells were lysed and luciferase activity was measured. Data represent the means 
standard errors of at least three independent experiments. Brackets indicate the statistically significant differences. *, P 0.05. NS, not significant.
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Transfection of HEK293 cells with plasmids encoding a
dominant-negative NOD1 protein (Nod1DN) or a dominant-
negative RIP2 protein (Rip2DN) inhibited NF-B activation elic-
ited by stimulation with the NOD1 ligand C12-iE-DAP (Fig. 4A).
Similarly, transfection of HEK293 cells with dominant-negative
NOD2 (Nod2DN) or Rip2DN inhibitedNF-B activation elicited
FIG 4 SipA-mediated NF-B activation requires both NOD1 and NOD2 in vitro. (A to C) HEK293 cells were transfected with the NF-B luciferase reporter
construct and hNOD1DN, hNOD2DN, hRIP2DN, or vector only and stimulated with 1g/ml C12-iE-DAP (NOD1 ligand) (A), 10g/mlMDP (NOD2 ligand)
(B), and 100 ng/ml purified flagellin (C). (D and E) HEK293 cells were cotransfected with the NF-B luciferase reporter construct and GFP-SipA (D) or
GFP-SipA425 (E) and hNOD1DN, hNOD2DN, hRIP2DN, or vector only.Data are expressed as percentNF-B inhibition, where 100%was set to be the response
in the cells transfected with vector only. Values represent the means standard errors of at least three independent experiments. Brackets indicate the statistical
differences. NS, not significant. (F)Western blot analysis of HEK293 cells expressingGFP-tagged SipA425 and Flag-tagged hNOD1DN, Flag-tagged hNOD2DN,
HA-tagged hRIP2DN, or vector only. Cotransfection did not influence the expression of GFP-SipA425.
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by stimulation with the NOD2 ligand muramyl dipeptide (MDP)
(Fig. 4B). Dominant-negative forms of NOD1 (Nod1DN), NOD2
(Nod2DN), or RIP2 (Rip2DN) did not inhibit NF-B activation
in HEK293 cells stimulated with flagellin (FliC) (Fig. 4C). Impor-
tantly, transfection of HEK293 cells with dominant-negative
forms of NOD1 (Nod1DN), NOD2 (Nod2DN), or RIP2
(Rip2DN) inhibited NF-B activation elicited by ectopic expres-
sion of GFP-SipA or GFP-SipA425 (P  0.05) (Fig. 4D and 4E).
Cotransfection of the dominant-negative forms ofNOD1,NOD2,
or RIP2 with GFP-SipA425 did not markedly affect protein ex-
pression of SipA425 (Fig. 4F). Ectopic expression excluded the
possibility that SipA-mediated NF-B activation was due to con-
tamination with endogenous bacterial ligands, such asMDP. Fur-
thermore, both NOD1 and NOD2 contributed to NF-B activa-
tion in response to ectopic expression of SipA (Fig. 4D), while
responses to C12-iE-DAP required only NOD1 (Fig. 4A) and re-
sponses toMDP required onlyNOD2 (Fig. 4B). Collectively, these
data suggested that SipA activated NOD1/NOD2 through a path-
way that was distinct from that observed with bacterial cell wall
fragments.
To investigate interaction of SipA with NOD1, HEK293 cells
were transfected with Flag-tagged NOD1 protein (NOD1-Flag)
and eitherMyc-tagged SipAprotein (Myc-SipA) orGFP-SipA425.
After immunoprecipitation of Flag-NOD1 with anti-Flag anti-
body, SipA was detected in the immunoprecipitate (Fig. 5). Fur-
thermore, colocalization of SipA and NOD1 was observed micro-
scopically in someHEK293 cells transfected with NOD1-Flag and
GFP-SipA (see Fig. S3 in the supplemental material). Collectively,
these data suggested that SipA either interacts withNOD1 directly
or is present in a protein complex that contains NOD1.
SipA does not trigger mucosal inflammation in NOD1/
NOD2-deficient mice. To test the biological significance of our
observations, we determined the role of NOD1/NOD2 in SipA-
mediated inflammation in vivo using the mouse colitis model of
S. Typhimurium infection (4). The T3SS effectors SipA, SopA,
SopB, SopD, and SopE2 act in concert to trigger intestinal inflam-
FIG 5 Coimmunoprecipitation of NOD1 and SipA. At 48 hours after transfection of HEK293 cells with the indicated constructs, immunoprecipitation was
performed using anti-Flag antibodies. Proteins were detected in whole-cell lysates and immunoprecipitates by Western blot analysis with anti-Flag antibody
(-Flag), anti-Myc antibody (-myc), or anti-GFP antibody (-GFP).
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mation (12). To restrict our analysis to SipA-mediated mecha-
nisms of inflammation, we compared an S. Typhimurium strain
producing only SipA (sopABDE2 mutant) with an isogenic SipA-
deficient mutant (sipA sopABDE2 mutant). Remarkably, the
SipA-proficient S. Typhimurium strain (sopABDE2mutant) trig-
geredmucosal inflammation inwild-typemice (C57BL/6) but not
in the NOD1/NOD2-deficient mice 2 days after infection (Fig. 6;
see also Fig. S4 in the supplemental material). NOD1/NOD2-
deficientmice failed to induce SipA-dependent expression of Ifng,
the gene encoding gamma interferon (IFN-) (Fig. 6A), andTnfa,
the gene encoding tumor necrosis factor alpha (TNF-) (Fig. 6B),
in the cecal mucosa. Wild-type (C57BL/6) mice infected with the
SipA-proficient S. Typhimurium strain (sopABDE2 mutant) ex-
hibited marked intestinal inflammation, which was absent in
wild-type mice infected with the SipA-deficient mutant (sipA sop-
ABDE2 mutant) or in NOD1/NOD2-deficient mice (Fig. 6C; see
also Fig. S4). In summary, a SipA-proficient S. Typhimurium
FIG 6 Inflammatory responses in themouse colitis model. C57BL/6mice (wild type, black bars) andNOD1/NOD2-deficientmice (white bars) were inoculated
with the S. Typhimurium sopABDE2mutant, the S. Typhimurium sipA sopABDE2mutant, or sterile medium (mock infected), and cecal tissue was collected at
48 hours after infection. (A andB)Relative Ifng (A) andTnfa (B) transcript levels in the cecal tissuewere determined by quantitative real-timePCR. Bars represent
the geometric means  standard errors from eight different animals. Brackets indicate the statistical significance of differences. NS, not significant. (C)
Histopathological analysis of the cecal mucosa. Boxes in whisker plots represent the second and third quartiles of combined histopathology scores, while lines
indicate the first and fourth quartiles. Brackets indicate the statistical significance of differences. NS, not significant.
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strain required NOD1/NOD2 for eliciting intestinal inflamma-
tion.
DISCUSSION
The translocation ofmultiple proteins by the T3SS-1 canmask the
contribution of an individual pathway to inflammation in vivo.
For example, previous studies show that S. Typhimurium can in-
duce inflammation in mice deficient for MyD88, RIP2, or caspase
1 (31). However, whenmice are infected with an S. Typhimurium
strain translocating only the SopE protein (sipA sopB sopE2 sseD
mutant), it becomes apparent that caspase 1 activation contrib-
utes to mucosal inflammation in the mouse colitis model (32).
Similarly, here we show that a contribution of NOD1/NOD2 sig-
naling to inflammation is apparentwhenmice are infectedwith an
S. Typhimurium strain that translocates SipA but carries muta-
tions in genes encoding other T3SS-1 effector proteins involved in
eliciting intestinal inflammation.
SipA is a protein delivered into the host cell cytosol by the
invasion-associated T3SS of S. Typhimurium (6). SipA contrib-
utes to invasion of epithelial cell lines by modulating actin assem-
bly through its C-terminal ABD (6, 9–11, 25). The N-terminal
425 amino acids of SipA trigger neutrophil transepithelial migra-
tion in vitro (33–36). Finally, SipA contributes to intestinal in-
flammation in vivo (12, 37), but the underlying mechanism has
remained unclear. Here we show that the proinflammatory effects
of SipA required NOD1/NOD2 activity. Furthermore, in vitro ex-
periments demonstrated that SipA was necessary and sufficient
forNOD1/NOD2-dependentNF-B activation, a process that did
not require its ABD. These data suggested that cytosolic sensing of
SipA by the pattern recognition receptors NOD1 and NOD2
served as a signal for cytosolic access by the invasion-associated
T3SS-1 of S. Typhimurium, thereby escalating mucosal inflam-
matory responses. Consistent with this idea, SipA enhanced mu-
cosal inflammation in themouse colitismodel in aNOD1/NOD2-
dependent fashion.
MATERIALS AND METHODS
Bacterial strains, tissue culture cells, and culture conditions. S. Typhi-
murium strain IR715 (38), a fully virulent, nalidixic acid-resistant deriv-
ative of American Type Culture Collection (ATCC) isolate 14028, was
used as a wild-type isolate. IR715 derivatives carrying mutations in invA
(SPN449) (39); in sopA, sopB, sopD, and sopE2 (ZA20) (12); and in sipA,
sopA, sopB, sopD, and sopE2 (ZA21) (12) have been described previously.
Plasmids carrying the sopD gene (pMR15), the sopE2 gene (pMR17), the
sopB gene (pMR26), the sopA gene (pMR28), or the sipA gene (pMR29)
from S. Typhimurium have been described previously (10). The sipA425,
sipA290, and sipA149 fragments of the sipA gene were amplified without
the sipA promoter from pMR29 and cloned directionally behind the lac
promoter of cloning vector pWSK29 (40) with BamHI and XbaI. Plasmid
pRI203, encoding the Yersinia pseudotuberculosis invasin protein, has
been described previously (22). Bacteria were grown aerobically at 37°C in
Luria-Bertani (LB) broth supplemented with antibiotics. The HeLa 57A
cell line stably transfected with an NF-B luciferase reporter construct
(41) was generously provided by R. T. Hay (the Wellcome Trust Centre
for Gene Regulation and Expression, College of Life Sciences, University
of Dundee, United Kingdom). The HEK293 cell line was purchased from
ATCC. HeLa 57A cells and HEK293 cells were maintained in Dulbecco’s
modified Eagle’s medium (DMEM) containing 10% fetal calf serum
(FCS) at 37°C in a 5% CO2 atmosphere.
Construction of expression plasmids.The sipA gene was PCR ampli-
fied from the chromosome of S. Typhimurium IR715, and the obtained
product was cloned into the mammalian expression vector pEGFP-C1
(BD Biosciences Clontech). The mutant forms of sipA were PCR ampli-
fied from pEGFP-SipA and cloned in pEGFP-C1. Expression vectors with
deletions in the F1 domain (pEGFP-F1ABD) and in the F2 domain
(pEGFP-F2) were engineered by overlap extension PCR. The two DNA
fragments needed for the construction of these sipA mutant forms were
amplified by PCR, gel purified, and fused in one PCR. The full-length sipA
and the mutant forms were expressed as a fusion to the C terminus of the
enhanced GFP (EGFP). Construction of Myc-SipA was obtained by clon-
ing the full-length sipA generated by PCR from pEGFP-SipA into pCMV-
myc (Clontech). The full-length human NOD1 and dominant-negative
versions of human NOD1 (hNOD1) and hNOD2 were PCR amplified
from pUNO-hNOD1 and pUNO-hNOD2 (InvivoGen), respectively.
hNOD1DN (amino acids [aa] 127 to 954) lacks the N-terminal caspase
recruitment domain (CARD). hNOD2DN (aa 217 to 1041) lacks the two
N-terminal CARDs. The obtained PCR products were cloned into a de-
rivative of themammalian expression vector pTracer-CMV2 (Invitrogen,
Life Technologies). The derivative lacks the GFP gene and contains a
3Flag tag at the C-terminal cloning site (42). The human RIP2 gene was
PCR amplified from cDNA prepared from HEK293 cells. The obtained
PCR product was cloned into pTracer-CMV2, yielding pTracer-hRIP2
(aa 1 to 540). The dominant-negative form of hRIP2 (aa 1 to 434), lacking
the C-terminal CARD, was PCR amplified from pTracer-hRIP2 and
cloned into pCMV-HA (Clontech). The hemagglutinin (HA) tag is fused
to the N terminus of hRIP2DN. The plasmid pDeNy-MyD88 expressing a
dominant-negative humanMyD88 gene was purchased from InvivoGen.
All constructs were verified by DNA sequencing.
Gentamicin protection assay. HEK293 and HeLa 57A cells were
seeded in a 24-well tissue culture plate at approximately 50% confluence.
At the time of infection, the cells had a confluence of approximately 100%.
Overnight cultures of S. Typhimurium strains were diluted 1 in 50 and
grown for 3 h at 37°C. HEK293 and HeLa 57A cells were infected with
S. Typhimurium strains at approximately 107 CFU/ml. The bacteria were
incubated for 1 h at 37°C to allow invasion. The cells were washed three
times with Dulbecco’s phosphate-buffered saline (DPBS; pH 7.4) to re-
move extracellular bacteria, DMEM containing 10% FCS and gentamicin
(0.1 mg/ml) was added, and the cells were incubated for 90 min at 37°C.
The cells were washed in DPBS and lysed with 0.5 ml of 1% Triton X-100,
and the lysates were transferred to a sterile Eppendorf tube. Thewells were
washed with 0.5 ml PBS and transferred to the Eppendorf tubes. Serial
dilutions were plated on LB plates with the appropriate antibiotics to
count the intracellular bacteria.
Transient transfection. HEK293 cells were grown in 24- or 48-well
tissue culture plates in DMEM containing 10% FCS until 40% confluence
was reached (~24 h). HEK293 cells were transiently transfected with a
total of 250 ng of plasmidDNA, consisting of 25 ng of the reporter plasmid
pNF-B-luc, 25 ng of normalization vector pTK-LacZ, and 200 ng of
either empty control vector, pUNO-hMyD88DN (InvivoGen), or
pEGFP-SipA constructs. For the cotransfection experiments with pEGFP-
SipA constructs and hNOD1DN-3Flag, hNOD1DN-3Flag, or HA-
hRIP2DN, 100 ng of DNA for each plasmid was used. FuGene HD
(Roche) was used as transfection reagent at a lipid-to-DNA ratio of 5 to 1.
After 48 h of incubation, the cells were infected with the appropriate
bacterial strains or the NOD1 ligand C12-iE-DAP, the NOD2 ligand
MDP, or the TLR5 ligand flagellin (InvivoGen).
Luciferase assays. NF-B activation was assessed using the NF-B--
luciferase reporter system. HeLa 57A cells stably transfected with an NF-
B--luciferase reporter construct and transiently transfected HEK293
cells were infected with the indicated S. Typhimurium strains (107 CFU/
ml) for 3 h, after which the cells were washed with DPBS and incubated at
37°C for an additional 2 h in the presence of DMEMcontaining 10% FCS.
The cells were washed in DPBS and lysed in 0.1 ml of reporter lysis buffer
(Promega). Firefly luciferase activity was measured with the luciferase
assay system (Promega) using a plate reader. For normalization of the
efficiency of transfection, luciferase values were adjusted to
-galactosidase values as determined with the -galactosidase assay (Pro-
Keestra et al.
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mega). Results were expressed as fold increase over the uninfected con-
trols.
Protein expression analysis. HEK293 cells transfected with fusion
proteins were lysed in lysis buffer (50 mM Tris-HCl, pH 7.6, 150 mM
NaCl, 0.2% [vol/vol] NP-40, and 1 mM EDTA). An 0.01-mg amount of
total protein was separated by SDS-polyacrylamide gel electrophoresis.
Proteins were transferred to a polyvinylidene fluoride membrane (Milli-
pore) in a semidry transfer process (Bio-Rad). The membranes were in-
cubated in PBS containing 3% nonfat dry milk and 0.05% Tween 20 to
block nonspecific binding. The membranes were incubated with poly-
clonal primary antibodies raised against tubulin (Cell Signaling Technol-
ogy), mouse anti-Flag (Sigma), or mouse anti-HA (Covance). For GFP
detection, a horseradish peroxidase (HRP)-conjugated anti-GFP anti-
body (Cell Signaling Technology) was used. HRP-conjugated anti-mouse
IgG and HRP-conjugated anti-rabbit IgG (Promega) were used as the
secondary antibodies for tubulin, Flag, and HA detection. Horseradish
peroxidase activity was visualized by adding Immobilon Western chemi-
luminescent substrate (Millipore) to the membrane. Images were re-
corded and processed by a BioSpectrum imaging system (UVP).
Coimmunoprecipitation. HEK293 cells were transiently transfected
for 48 h and lysed with lysis buffer (50 mM Tris-HCl, pH 7.6, 150 mM
NaCl, 0.1% [vol/vol] NP-40, 1mMEDTA, and protease inhibitors). Sam-
ples of the whole-cell lysate were collected for analysis by SDS-PAGE and
immunoblotting. The whole-cell lysate was incubated for 2 h at 4°C with
Dynal protein G beads (Invitrogen) coated with anti-Flag M2 antibody
(Sigma). After 10 washes with the lysis buffer and 2 washes with 50 mM
ammonium bicarbonate, samples of the immunoprecipitate were col-
lected and subjected to SDS-PAGE and immunoblotting. The proteins of
interest were detected with anti-Flag M2 antibody (Sigma), anti-Myc an-
tibody (Cell Signaling), and anti-GFP antibody (Sigma).
Fluorescence microscopy. HEK293 cells were transfected with GFP-
SipA andNOD1-Flag. After 48 h, the cells were washed and fixed with 3%
paraformaldehyde. The cells were permeabilized with 0.1% saponin-10%
goat serum (blocking reagent) in PBS for 30 minutes at room tempera-
ture. After blocking, cells were incubated with anti-Flag M2 antibody
(1:1,000 dilution; Sigma) in 0.1% saponin and 10% goat serum in PBS for
1 h at room temperature. The cells were rinsed twice in 0.1% saponin in
PBS and then twice in PBS and incubated (1 h) with Alexa Fluor 647 goat
anti-mouse IgG (1:1,000 solution; Invitrogen). After the cells were rinsed
twice in 0.1% saponin in PBS, twice in PBS, and once in H2O, they were
embedded in Fluorsave (Calbiochem) and analyzed with an LSM700 con-
focal microscope (Zeiss).
Animal experiments. Streptomycin (20 mg/mouse) (Sigma)-
pretreated C57BL/6 mice (Jackson Laboratory) and NOD1/NOD2-
deficient mice (generously provided by D. Portnoy) were mock infected
with 0.1 ml of sterile LB broth or infected orally with 1  109 CFU (in
0.1 ml of LB broth) of an S. Typhimurium sopABDE2mutant (ZA20) or a
sipA sopABDE2 mutant (ZA21) carrying the plasmid pHP45 to confer
streptomycin resistance. At 48 h after infection, mice were sacrificed, and
samples of the cecum were snap-frozen in liquid nitrogen for isolation of
mRNA.
Histopathology. Formalin-fixed, hematoxylin- and eosin-stained ce-
cal tissue sections were blinded for evaluation by a veterinary pathologist.
The following pathological changes were scored: (i) neutrophil infiltra-
tion, (ii) infiltration by mononuclear cells, (iii) submucosal edema, (iv)
epithelial damage, and (v) inflammatory exudate. The pathological
changes were scored on a scale from 0 to 4 as follows: 0, no changes; 1,
detectable; 2, mild; 3, moderate; 4, severe. Images were taken using an
Olympus BX41 microscope.
Real-time PCR. Samples of the cecum were collected, immediately
snap-frozen in liquid nitrogen, and stored at80°C. RNA was extracted
using TriReagent (Molecular Research) according to the instructions of
the manufacturer. Reverse transcription was performed on 1 g of
DNase-treated RNAwith TaqMan reverse transcription reagent (Applied
Biosystems). For each real-time reaction, 4 l of cDNA was used. Real
time transcription-PCR (RT-PCR) was performed using Sybr green (Ap-
plied Biosystems) and an ABI 7900 RT-PCR machine (Applied Biosys-
tems). The fold change in mRNA levels was determined using the com-
parative threshold cycle (CT) method (Applied Biosystems). Target gene
transcription was normalized to the levels of glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) mRNA.
Statistical analysis. A paired Student t test was used to confirm statis-
tical significance in the tissue culture experiments. To determine statisti-
cal significance of the relative mRNA transcription between treatment
groups in the animal experiments, an unpaired Student t test was used. To
determine the statistically significant differences in the total histopathol-
ogy scores, a Mann-Whitney U test was used. A two-tailed P value of
0.05 was taken to be significant.
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